[go: up one dir, main page]

Adisornkanj et al., 2023 - Google Patents

Genetic variants in protein tyrosine phosphatase non-receptor type 23 are responsible for mesiodens formation. Biology. 2023; 12: 393

Adisornkanj et al., 2023

View PDF
Document ID
277845230181600180
Author
Adisornkanj P
Chanprasit R
Eliason S
Fons J
Intachai W
Tongsima S
Olsen B
Arold S
Ngamphiw C
Amendt B
et al.
Publication year

External Links

Snippet

A mesiodens is a supernumerary tooth located in the midline of the premaxilla. To investigate the genetic cause of mesiodens, clinical and radiographic examination were performed on 23 family members of a two-generation Hmong family. Whole exome …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates

Similar Documents

Publication Publication Date Title
Howard et al. IGSF 10 mutations dysregulate gonadotropin‐releasing hormone neuronal migration resulting in delayed puberty
Uddin et al. OTUD7A regulates neurodevelopmental phenotypes in the 15q13. 3 microdeletion syndrome
Zhang et al. A founder mutation in VPS11 causes an autosomal recessive leukoencephalopathy linked to autophagic defects
Gee et al. ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling
Nakanishi et al. Functional significance of rare neuroligin 1 variants found in autism
Stoupa et al. TUBB 1 mutations cause thyroid dysgenesis associated with abnormal platelet physiology
Gomes Genetics of proteasome diseases
JP4544865B2 (en) Targets, methods, and reagents for diagnosis and treatment of schizophrenia
Lahrouchi et al. Homozygous frameshift mutations in FAT1 cause a syndrome characterized by colobomatous-microphthalmia, ptosis, nephropathy and syndactyly
Li et al. A dominant negative mutation at the ATP binding domain of AMHR2 is associated with a defective anti-Müllerian hormone signaling pathway
Gervasini et al. Molecular characterization of a mosaic NIPBL deletion in a Cornelia de Lange patient with severe phenotype
Tian et al. Somatic mutations in planar cell polarity genes in neural tissue from human fetuses with neural tube defects
França et al. A novel homozygous 1-bp deletion in the NOBOX gene in two Brazilian sisters with primary ovarian failure
Fulton et al. Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndrome
Zhang et al. CEP112 coordinates translational regulation of essential fertility genes during spermiogenesis through phase separation in humans and mice
Wang et al. Patient with multiple morphological abnormalities of sperm flagella caused by a novel ARMC2 mutation has a favorable pregnancy outcome from intracytoplasmic sperm injection
Wang et al. Whole-exome sequencing identifies damaging de novo variants in anencephalic cases
Adisornkanj et al. Genetic variants in protein tyrosine phosphatase non-receptor type 23 are responsible for mesiodens formation
Du et al. Functional characterization of novel NPRL3 mutations identified in three families with focal epilepsy
Oleari et al. Autism-linked NLGN3 is a key regulator of gonadotropin-releasing hormone deficiency
Redig et al. Allelic interaction between CRELD1 and VEGFA in the pathogenesis of cardiac atrioventricular septal defects
Miyake et al. Clinical features of SMARCA2 duplication overlap with Coffin–Siris syndrome
Chang et al. A novel homozygous nonsense variant of AK7 is associated with multiple morphological abnormalities of the sperm flagella
Barton et al. IRE1α–XBP1 safeguards hematopoietic stem and progenitor cells by restricting pro-leukemogenic gene programs
Dong et al. Discovery of BMP10 as a new gene underpinning congenital heart defects